Page 127 - Read Online

Page 340 Jiang et al. J Transl Genet Genom 2021;5:323-40 https://dx.doi.org/10.20517/jtgg.2021.21

cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br J Cancer 2006;94:599-608. DOI PubMed PMC
103. Nakhoul H, Lin Z, Wang X, Roberts C, Dong Y, Flemington E. High-throughput sequence analysis of peripheral T-Cell lymphomas
indicates subtype-specific viral gene expression patterns and immune cell microenvironments. mSphere 2019;4:e00248-19. DOI
PubMed PMC
104. Qiu J, Thorley-Lawson DA. EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral
replication in B cells. Proc Natl Acad Sci U S A 2014;111:11157-62. DOI PubMed PMC
105. Iizasa H, Wulff BE, Alla NR, et al. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and
consequently affects viral latency. J Biol Chem 2010;285:33358-70. DOI PubMed PMC
106. Jung YJ, Choi H, Kim H, Lee SK. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1
and BRLF1. J Virol 2014;88:9027-37. DOI PubMed PMC
107. Bollard CM, Gottschalk S, Torrano V, et al. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic
T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol 2014;32:798-808. DOI PubMed PMC
108. McLaughlin LP, Rouce R, Gottschalk S, et al. EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after
allogeneic bone marrow transplantation. Blood 2018;132:2351-61. DOI PubMed PMC
109. Ando M, Ando J, Yamazaki S, et al. Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced
pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo. Haematologica 2020;105:796-807. DOI
PubMed PMC
110. Burr ML, Sparbier CE, Chan YC, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature
2017;549:101-5. DOI PubMed PMC